相关实验视频

Updated: Jul 20, 2025

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Osmotic Minipump Implantation for Increasing Glucose Concentration in Mouse Cerebrospinal Fluid

Published on: April 7, 2023

酸可以改善记忆功能,并减少前叶炎症在糖尿病老鼠

F Munawaroh¹, N Arfian², L A A W S Saputri¹

¹Universitas Gadjah Mada, Faculty of Medicine, Public Health and Nursing, Yogyakarta, Indonesia.

The Medical journal of Malaysia

|July 31, 2023

概括

酸 (CGA) 改善了记忆功能,并减少了糖尿病大鼠的大脑炎症. 这项研究表明CGA.

科学领域:

神经科学是一个神经科学.
药理学药理学是指药理学的学科.
内分泌学在内分泌学.

背景情况:

糖尿病类糖尿病 (DM) 可以导致糖尿病脑病,其特征是记忆功能障碍.
在DM中,高血糖会激活像NF-κB这样的神经元炎症通路,导致增强的促炎剂 (MCP-1,IL-6) 和质细胞激活 (GFAP).
酸 (CGA) 具有抗炎性质,并显示有改善记忆功能的潜力.

研究的目的:

为了研究CGA对糖尿病大鼠前额叶的抗炎作用.
评估CGA在糖尿病脑病情背景下对记忆功能的影响.
分析由CGA对NF-κB,MCP-1,IL-6和GFAP的mRNA表达的调节.

主要方法:

雄性大鼠被分为控制,DM和不同剂量的CGA治疗组.
用RT-PCR分析了前额叶组织以检测NF-κB,MCP-1,IL-6和GFAP的mRNA表达.
免疫组织化学被用来评估额叶组织中的质细胞激活 (GFAP).

主要成果:

在所有测试剂量中,CGA的使用显著改善了记忆功能.
与未经治疗的糖尿病大鼠相比,CGA治疗组中NF-κB,MCP-1,IL-6和GFAP的mRNA表达显著降低.
CGA2组 (25 mg/KgBW) 显示NF-κB和IL-6mRNA表达的显著减少以及大脑炎症活动的减少.

结论:

在糖尿病老鼠中,CGA有效地改善了记忆功能.
CGA在大脑中表现出显著的抗炎作用,减少炎症和质激活的关键标志物.
在治疗糖尿病脑病及其相关认知缺陷方面,CGA具有治疗潜力.

更多相关视频

Barnes Maze Testing Strategies with Small and Large Rodent Models

Barnes Maze Testing Strategies with Small and Large Rodent Models

Published on: February 26, 2014

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Alternate Immersion in Glucose to Produce Prolonged Hyperglycemia in Zebrafish

Published on: May 5, 2021

相关概念视频

Psychoneuroimmunology: Diabetes and Cancer

Psychoneuroimmunology: Diabetes and Cancer

Chronic stress has been linked to both the onset and progression of serious health conditions, including Type 2 diabetes and cancer. Type 2 diabetes, a widespread chronic illness, is closely associated with obesity and insulin resistance, both of which often worsen under stress. Studies indicate that men experiencing high levels of chronic stress face a 45% higher risk of developing diabetes compared to those with minimal stress. Stress triggers physiological responses that elevate blood...

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

Oral Hypoglycemic Agents: α-Glucosidase Inhibitors

α-glucosidase inhibitors, including acarbose (Precose), miglitol (Glyset), and voglibose (Voglib) (primarily available in Asia), are drugs that control blood sugar levels by delaying the digestion of starch and disaccharides. They achieve this by inhibiting α-glucosidase enzymes in the intestine, which slow the absorption of carbohydrates in the intestine, which in turn leads to a prolonged release of the glucoregulatory hormone GLP-1 from intestinal L-cells.
Acarbose and miglitol are...